CD19 and neoplasm: The analysis of tumor infiltrate revealed the increased frequency of CD19+ lymphocytes and, among myeloid cells, of putative M-MDSC and DC into the tumor bed 96 h after CTX treatment (Supplementary Figure S1D,E), as previously reported [50].